A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese Subjects
Clinical trial NCT06040372 · COMPLETED
Trial details
- NCT number
- NCT06040372
- Sponsor
- LG Chem
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2022-03-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.